CTBP2P3

Across TCGA pan-cancer cohorts, CTBP2P3 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of CTBP2P3’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where CTBP2P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CTBP2P3 is over-expressed in tumor.

STAD and BRCA are the cancer types where CTBP2P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CTBP2P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	III,IV	+0.031	.029	2	view →
BRCA	All	III,IV	+0.013	.025	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

CTBP2P3–STAD

Open the STAD breakdown →